1Department of Pulmonary Diseases, Biruni University Medical Faculty, Istanbul, Turkey.
2Department of Internal Medicine, Biruni University Medical Faculty, Istanbul, Turkey.
Am J Trop Med Hyg. 2021 Apr 1;104(5):1713-1715. doi: 10.4269/ajtmh.21-0190.
Two cases are presented with coronavirus disease 19 (COVID-19)-related hiccups: one during initial presentation and one 10 days after COVID-19 diagnosis. Hiccups in both patients were resistant to treatment and responded only to chlorpromazine. COVID-19 patients may present with hiccups and also may have hiccups after treatment. Resistant hiccups without any underlying disease other than COVID-19 should be considered in association with COVID-19 and may respond well to chlorpromazine.
现报告两例与 2019 冠状病毒病(COVID-19)相关的呃逆病例:一例发生在初次就诊时,另一例发生在 COVID-19 诊断后 10 天。两例患者的呃逆均对治疗有抵抗性,仅对氯丙嗪有反应。COVID-19 患者可能会出现呃逆,并且在治疗后也可能会出现呃逆。除 COVID-19 之外没有任何潜在疾病的顽固性呃逆应与 COVID-19 相关联,并且可能对氯丙嗪反应良好。